Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Hormones and genes affect hair growth and male baldness.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Early treatment of acne is crucial to prevent scarring and psychological effects.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.